Imperatorin is widely studied for its pharmacological properties, particularly in traditional medicine and modern drug research. It exhibits significant anti-inflammatory effects, making it useful in the development of treatments for inflammatory diseases such as arthritis and asthma. The compound also shows neuroprotective activity, supporting its potential use in managing neurodegenerative disorders like Alzheimer’s and Parkinson’s disease.

It has demonstrated anticonvulsant properties, suggesting a role in epilepsy treatment. In cancer research, imperatorin induces apoptosis and inhibits proliferation in various cancer cell lines, including those of the breast, liver, and colon, highlighting its potential as an anticancer agent.

Additionally, imperatorin possesses antimicrobial and antifungal activities, useful in combating resistant microbial strains. It also acts as a photosensitizer in photodynamic therapy, enhancing the effects of light-based treatments for skin conditions and certain cancers. Its ability to modulate enzyme activity, especially cytochrome P450, influences drug metabolism and is considered in drug interaction studies. Studies also indicate potential antiviral properties against certain viruses.